Skip to main content

Achilles Tendinopathy

4
Pipeline Programs
7
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
3
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
3100%
+ 3 programs with unclassified modality

Competitive Landscape

6 companies ranked by most advanced pipeline stage

Zimmer Biomet
Zimmer BiometFL - Jacksonville
1 program
1
PRP Injection with eccentric exercisesPhase 41 trial
Active Trials
NCT00761423Completed81Est. Aug 2009
MSD
MSDIreland - Ballydine
1 program
1
etoricoxibPhase 4Small Molecule1 trial
Active Trials
NCT00792376Completed56Est. Feb 2012
Sharp Therapeutics
Sharp TherapeuticsPA - Pittsburgh
1 program
1
etoricoxibPhase 4Small Molecule
Sandoz
SandozAustria - Kundl
1 program
1
NGI226Phase 21 trial
Active Trials
NCT05592990Completed45Est. Feb 2026
Bioiberica
BioibericaSpain - Barcelona
1 program
TendoactiveN/A1 trial
Active Trials
NCT01691716Completed100Est. Sep 2013
Merck & Co.
Merck & Co.RAHWAY, NJ
1 program
etoricoxibPHASE_4Small Molecule

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
MSDetoricoxib
Zimmer BiometPRP Injection with eccentric exercises
SandozNGI226
BioibericaTendoactive

Clinical Trials (4)

Total enrollment: 282 patients across 4 trials

NCT00792376MSDetoricoxib

"NSAIDs in Acute Achilles Tendinopathy: Effect on Pain Control, Leg Stiffness and Functional Recovery in Athletes"

Start: Aug 2009Est. completion: Feb 201256 patients
Phase 4Completed
NCT00761423Zimmer BiometPRP Injection with eccentric exercises

The Value of Platelet-Rich Plasma in Chronic Midportion Achilles Tendinopathy: a Double-blind Randomized Clinical Trial

Start: Aug 2008Est. completion: Aug 200981 patients
Phase 4Completed

A Study to Investigate the Safety, Tolerability and Preliminary Efficacy of NGI226 Microparticles in Patients With Achilles Tendinopathy

Start: Jun 2023Est. completion: Feb 202645 patients
Phase 2Completed

The Efficacy of Tendoactive, Eccentric Training, and the Combination of Both as a Treatment of Achilles Tendinopathy

Start: Apr 2012Est. completion: Sep 2013100 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

7 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.